Illumina Fined $9.8M for Cybersecurity Flaws in Genomic Tools Sold to U.S. Agencies
Illumina Inc., a leading genomic sequencing company, has agreed to pay $9.8 million to settle federal allegations that it knowingly sold cybersecurity-vulnerable genomic sequencing systems…